Metabolic disturbances in liver cirrhosis (part 2), hepatogenous diabetes: Diagnostic aspects and treatment;Metabolische Störungen bei Leberzirrhose (Teil 2): Hepatogener Diabetes mellitus: Aktueller Stand der Diagnostik und Therapie

Deutsche Medizinische Wochenschrift

Volumn 135, Issue 1-2, 2010, Pages 22-24

  Gundling, F ^a   Seidl, H ^a   Loffler N ^a   Strassen, I ^a   Schepp, W ^a  

^a Munich Municipal Hospital   (Germany)

Author keywords

Complications; Hepatogenous diabetes; Insulin treatment; Liver cirrhosis; Oral antidiabetic drugs

Indexed keywords

GLIBENCLAMIDE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PIOGLITAZONE; ROSIGLITAZONE; ANTIDIABETIC AGENT;

DIABETES MELLITUS; HEPATOGENOUS DIABETES; HUMAN; LIVER CIRRHOSIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; PATHOPHYSIOLOGY; PREVALENCE;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; LIVER CIRRHOSIS; PREVALENCE;

EID: 73449147688     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1244811     Document Type: Review

References (18)

1. Bosch J, Gomis R, Kravetz D, et al. Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis. Am J Physiol 1984 247 G206-212
2. Gentile S, Guarino G, Romano M, et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005 3 184-191
3. Gundling F, Schepp W. Ernährung bei Leberzirrhose. Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr 2008 133 846-851
4. Gundling F, Seidl H, Löffler N, et al. Metabolische Störungen bei Leberzirrhose (Teil 1): Hepatische Osteopathie und Malnutrition. Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr 2009 134 2461-2464
5. Holstein A, Hinze S, Thiessen E, et al. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002 17 677-681
6. Huo T I., Lui W Y., Huang Y H., et al. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 2003 98 2293-2298
7. Imano E, Nishida T, Shibata M, et al. Significance of Oral Glucose Tolerance Test for the Diagnosis of Diabetes mellitus in Patients with Liver Cirrhosis. Int Med 1999 38 918-918
8. Kihara Y, Ogami Y, Tabaru A, et al. Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose. J Gastroenterol 1997 32 777-782
9. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997 73 204-207 (Pubitemid 27448819)
10. Moreau R, Chagneau C, Heller J. Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose. Scand J Gastroenterol 2001 36 303-308
11. Nishida T, Tsuji S, Tsujii M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006 101 70-75
12. Perseghini G, Mazzaferro V, Sereni L P., et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 2000 31 694-703
13. Petrides A S. Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis. Z Gastroenterol 1999 Suppl 1 15-21
14. Promrat K, Lutchman G, Uwaifo G I., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004 39 188-196
15. Schnedl W J., Wallner S J., Piswanger C, et al. Glycated hemoglobin and liver disease in diabetes mellitus. Wien Med Wochenschr 2005 155 411-415
16. Shetty A, Wilson S, Kuo P, et al. Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 2000 69 2451-2454
17. Siegel E G., Gallwitz B, Schmidt W E., et al. Hepatogenic diabetes-the current concepts of its pathophysiology and therapy. Dtsch Med Wochenschr 1999 124 1530-1535
18. Sigal S H., Stanca C M., Kontorinis N, et al. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006 101 1490-1496